Cash Flow Statement

Acquisitions Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Ratios

Purple Biotech (PPBT) Change in Intangibles (2022)

Purple Biotech has reported Change in Intangibles over the past 1 years, most recently at $1000.0 for Q3 2022.

Quarterly Change in Intangibles changed N/A to $1000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$202000.0 through Dec 2022, changed N/A year-over-year, with the annual reading at -$202000.0 for FY2022, N/A changed from the prior year.
Change in Intangibles was $1000.0 for Q3 2022 at Purple Biotech, up from -$203000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $1000.0 in Q3 2022 and troughed at -$203000.0 in Q1 2022.